Diabetic Macular Edema Market

Future Market Insights

Key Insight

The diabetic macular edema market is projected to grow from USD 4.2 billion in 2025 to USD 4.7 billion by 2035, at a CAGR of 1.2%. Ranibizumab (Lucentis) will dominate with a 45.0% market share, while intravitreal injections will lead the form segment with a 94.8% share.

October 23, 2025

Anurag Sharma

324 Pages

Cite this Report

Diabetic Macular Edema Market

https://www.futuremarketinsights.com/reports/diabetic-macular-edema-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Alimera Sciences Inc
Allergan plc
Bayer
Chugai Pharmaceutical Co. Ltd
F. Hoffmann-La Roche Ag
Bausch & Lomb Incorporated

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Diabetic Macular Edema Market

Key Players

Similar Industry Reports